Insider Selling: Omada Health (NASDAQ:OMDA) CAO Sells $37,494.00 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,083 shares of Omada Health stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $18.00, for a total value of $37,494.00. Following the transaction, the chief accounting officer owned 7,108 shares of the company’s stock, valued at $127,944. The trade was a 22.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Craig Gracey also recently made the following trade(s):

• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total value of $39,597.83.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The stock was sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Stock Up 10.5%

Shares of OMDA opened at $20.89 on Friday. The company has a market capitalization of $1.24 billion and a price-to-earnings ratio of -77.37. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92. The stock’s 50-day moving average price is $16.51 and its 200-day moving average price is $14.85.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million during the quarter. As a group, equities analysts anticipate that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on OMDA. BMO Capital Markets decreased their target price on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, March 6th. Morgan Stanley restated an “overweight” rating and set a $30.00 price target on shares of Omada Health in a research report on Monday. Wells Fargo & Company lifted their price objective on shares of Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Finally, The Goldman Sachs Group reissued a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $22.91.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Omada Health during the fourth quarter worth $1,222,000. Divisadero Street Capital Management LP purchased a new position in Omada Health during the third quarter valued at $30,510,000. a16z Perennial Management L.P. acquired a new stake in shares of Omada Health in the fourth quarter valued at about $2,480,000. Madryn Asset Management LP acquired a new stake in shares of Omada Health in the fourth quarter valued at about $9,212,000. Finally, Parallel Advisors LLC increased its stake in shares of Omada Health by 12,235.9% during the fourth quarter. Parallel Advisors LLC now owns 123,359 shares of the company’s stock worth $1,947,000 after purchasing an additional 122,359 shares in the last quarter.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.